COMT haplotypes, catecholamine metabolites in plasma and clinical response in schizophrenic and bipolar patients

被引:7
|
作者
Zumarraga, Mercedes [1 ]
Arrue, Aurora [1 ]
Basterreche, Nieves [2 ,3 ]
Macias, Isabel [4 ]
Catalan, Ana [5 ]
Madrazo, Arantza [5 ]
Bustamante, Sonia [5 ]
Zamalloa, Maria I. [1 ]
Erkoreka, Leire [3 ,6 ]
Gordo, Estibaliz [2 ]
Arnaiz, Ainara [2 ]
Olivas, Olga [7 ]
Arroita, Ariane [6 ]
Marin, Elena [8 ]
Gonzalez-Torres, Miguel A. [3 ,5 ]
机构
[1] Osakidetza, Hosp Zamudio, Red Salud Mental Bizkaia, Dept Invest Neuroquim, Arteaga Auzoa 45, Zamudio 48170, Bizkaia, Spain
[2] Osakidetza, Hosp Zamudio, Red Salud Mental Bizkaia, Unidad Hospitalizac Corta Estancia, Arteaga Auzoa 45, Zamudio 48170, Bizkaia, Spain
[3] Univ Basque Country, Fac Med, Dept Psiquiatria & Psicol Med, Barrio Sarriena S-N, Leioa 48940, Bizkaia, Spain
[4] Osakidetza, Red Salud Mental Bizkaia, Hosp Zamudio, Unidad Salud Laboral, Arteaga Auzoa 45, Zamudio 48170, Bizkaia, Spain
[5] Osakidetza, Hosp Basurto, Serv Psiquiatria, Ave Montevideo 18, Bilbao 48013, Spain
[6] Osakidetza, Red Salud Mental Bizkaia, Ctr Salud Mental Barakaldo, La Felicidad 9,3, Baracaldo 48901, Bizkaia, Spain
[7] Osakidetza, Red Salud Mental Bizkaia, Ctr Salud Mental Gernika, San Juan 1, Gernika 48300, Bizkaia, Spain
[8] Hosp Psiquiatr Bermeo, Tonpoi Bidea S-N, Bermeo 48370, Bizkaia, Spain
关键词
antipsychotics; bipolar disorder; COMT; haplotypes; plasma metabolites; schizophrenia; symptomatology; O-METHYLTRANSFERASE; HOMOVANILLIC-ACID; HUMAN BRAIN; FUNCTIONAL POLYMORPHISM; NONAFFECTIVE PSYCHOSIS; NEGATIVE SYMPTOMS; GENETIC-VARIATION; ETIOLOGIC FACTOR; MOOD DISORDERS; ASSOCIATION;
D O I
10.2217/pgs-2016-0022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aim: We examined the association of COMT haplotypes and plasma metabolites of catecholamines in relation to the clinical response to antipsychotics in schizophrenic and bipolar patients. Patients & methods: We studied 165 patients before and after four weeks of treatment, and 163 healthy controls. We assessed four COMT haplotypes and the plasma concentrations of HVA, DOPAC and MHPG. Results: Bipolar patients: haplotypes are associated with age at onset and clinical evolution. In schizophrenic patients, an haplotype previously associated with increased risk, is related to better response of negative symptoms. Conclusion: Haplotypes would be good indicators of the clinical status and the treatment response in bipolar and schizophrenic patients. Larger studies are required to elucidate the clinical usefulness of these findings.
引用
收藏
页码:837 / 851
页数:15
相关论文
共 50 条
  • [21] Plasma levels of metabolites of catecholamine in nicotine dependent patients treated with varenicline
    Nakano, W.
    Yoshimura, R.
    Hayashi, K.
    Ikenouchi-Sugita, A.
    Katsuki, A.
    Hori, H.
    Nakamura, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S594 - S594
  • [22] Prolactin plasma levels after neuroleptic challenge predict clinical response in schizophrenic patients
    Libiger, J
    Czobor, P
    Jirkalova, V
    Malirova, E
    Tuma, I
    HOMEOSTASIS IN HEALTH AND DISEASE, 1996, 37 (03): : 106 - 114
  • [23] PLASMA-CATECHOLAMINE METABOLITES AND TREATMENT RESPONSE AT NEUROLEPTIC STEADY-STATE
    BOWERS, MB
    SWIGAR, ME
    JATLOW, PI
    HOFFMAN, FJ
    BIOLOGICAL PSYCHIATRY, 1989, 25 (06) : 734 - 738
  • [24] Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients
    Liu, HC
    Chang, WH
    Wei, FC
    Lin, SK
    Lin, SK
    Jann, MW
    THERAPEUTIC DRUG MONITORING, 1996, 18 (02) : 200 - 207
  • [25] Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression
    Ueda, N
    Yoshimura, R
    Shinkai, K
    Nakamura, J
    PHARMACOPSYCHIATRY, 2002, 35 (05) : 175 - 181
  • [26] Gender differences in plasma clozapine levels and its metabolites in schizophrenic patients
    Jann, MW
    Liu, HC
    Wei, FC
    Lin, SK
    Lin, SK
    Hu, WH
    Chang, WH
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1997, 12 (05) : 489 - 495
  • [27] CORRELATION BETWEEN PLASMA CHLORPROMAZINE AND ITS METABOLITES AND CLINICAL RATINGS IN PATIENTS WITH ACUTE RELAPSE OF SCHIZOPHRENIC AND PARANOID PSYCHOSIS
    PHILLIPSON, OT
    MCKEOWN, JM
    BAKER, J
    HEALEY, AF
    BRITISH JOURNAL OF PSYCHIATRY, 1977, 131 (AUG) : 172 - 184
  • [28] Plasma cytokine response to surgical stress in schizophrenic patients
    Kudoh, A
    Sakai, T
    Ishihara, H
    Matsuki, A
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 125 (01): : 89 - 93
  • [29] PLASMA CLOZAPINE LEVELS AND CLINICAL-RESPONSE FOR TREATMENT-REFRACTORY SCHIZOPHRENIC-PATIENTS
    KRONIG, MH
    MUNNE, RA
    SZYMANSKI, S
    SAFFERMAN, AZ
    POLLACK, S
    COOPER, T
    KANE, JM
    LIEBERMAN, JA
    AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (02): : 179 - 182
  • [30] Plasma Levels of Metabolites of Catecholamine in Nicotine-Dependent Patients Treated With Varenicline
    Umene-Nakano, Wakako
    Yoshimura, Reiji
    Yoshii, Chiharu
    Hayashi, Kenji
    Ikenouchi-Sugita, Atsuko
    Katsuki, Asuka
    Hori, Hikaru
    Nakamura, Jun
    NICOTINE & TOBACCO RESEARCH, 2012, 14 (04) : 486 - 489